Biohaven Therapeutics co-led Artizan Biosciences’ latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.
Month: March 2021
Genomics gets its hands on $30m
The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.
Investors bet on Rivalry in $20m round
An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.
ClickPaas adds series B funding
The low-code app app development software provider’s eight-figure round included BAI and SIG Asia.
Reliance levitates to SkyTran acquisition
Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.
Gitai gets series B cash
Seiko Epson’s EP-GB fund and Dai-ichi Life helped provide $17.1m for Gitai as it prepares a demonstration of its space robotics technology.
Rising Stars Q&A – Wanja Humanes, Swisscom Ventures
Q&A with Wanja Humanes, investment manager, Swisscom Ventures
Mastercard and Citi bank on MoCaFi
Citi’s Impact Fund and Mastercard were among the investors as the mobile banking software provider secured $12m in series A funding.
Klarna collates $1bn
The instalment finance provider, which counts several corporates as investors, almost tripled its valuation to $31bn in the round.
Compass seeks $500m in initial public offering
SoftBank is the largest investor in the online real estate portal, which was valued at $6.4bn in its series G round early last year.
Vestiaire Collective unpacks $215m
Condé Nast and Kering joined new and returning investors to back a round valuing the fashion item resale platform in excess of $1bn.
Loggi locks up $205m
SoftBank and Microsoft have helped the last-mile delivery service increase its valuation to roughly $2bn in a round led by CapSur Capital.
DigitalOcean swims towards initial public offering
Access Industries is set to exit the cloud infrastructure technology developer, which has filed to raise up to $100m on the New York Stock Exchange.
Iluvatar CoreX caps off $186m series C
China Unicom has helped the Shanghai Electric-backed computer chip developer close a series C round that will fund commercialisation and research and development.